Lifastuzumab Biosimilar (NaPi2b / SLC34A2 Reference Antibody)
Lifastuzumab is a humanized anti-NaPi2b monoclonal antibody (IgG1 type) . Lifastuzumab can be coupled with monomethyl auristatin E (MMAE) through ADC Linker to form an antibody-drug conjugate (ADC) lifastuzumab vedotin (DNIB0600A) with anticancer activity.
Product Specifications
Target
Lifastuzumab Biosimilar (Anti-NaPi2b / SLC34A2 Reference Antibody)
Clonality
Recombinant
Conjugation
Unconjugated
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx149188-01 50 µg
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 20 (CEACAM20) Antibody
Sign In for Pricing
View Details abx149188-02 100 µg
Carcinoembryonic Antigen-Related Cell Adhesion Molecule 20 (CEACAM20) Antibody
Sign In for Pricing
View Details